Skip to content

13F-HR filed by Omega Fund Management, LLC

Omega Fund Management, LLC filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-14, with 12 holding rows worth $222,365,157.

Accession
0001193125-25-281790
Filed
2025-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2025

A holdings report, 12 entries on the cover page, a total value of $222,365,157 stated on the cover page (in dollars after the unit check, H1), rows summing to $222,365,157 with VALUE read as dollars as filed, 13F file number 028-16844. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
KESTRA MED TECHNOLOGIES LTDG52441105SHS1,645,893$39,106,418dollars as filed
BETA BIONICS INC08659B102COMMON STOCK1,920,125$38,152,884dollars as filed
BRIDGEBIO ONCOLOGY THERAPEUT107924102COM NEW3,289,661$38,094,274dollars as filed
BICARA THERAPEUTICS INC055477103COM2,204,650$34,811,424dollars as filed
NUVATION BIO INC COM CL A67080N101Stock8,831,089$32,675,029dollars as filed
UPSTREAM BIO INC91678A107COMMON STOCK1,356,293$25,511,871dollars as filed
IMAGENEBIO INC45175G207CMN455,361$3,711,192dollars as filed
ENGENE HOLDINGS INC29286M105COM526,357$3,595,018dollars as filed
SANA BIOTECHNOLOGY INC799566104COM843,750$2,995,313dollars as filed
ALUMIS INC022307102COM653,223$2,606,360dollars as filed
REPLIMUNE GROUP INC76029N106COMMON STOCK248,672$1,041,936dollars as filed
ENGENE HOLDINGS INC29286M113W EXP 10/31/202889,702$63,438dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001193125-25-281790this filing2025-11-14acceptance time not in the bulk data set